“…could be changed by modifying the structure and interfacial properties of the templates, e.g., using single crystals of metals such as gold, 13 organic crystals, 1,8,14 polymers, 15−17 Langmuir monolayers, 5 and surface-assembled monolayers. 18−20 A well-characterized example of templating has been provided by the pharmaceutical compound entacapone 2,6,7,21 which is important in the treatment of Parkinson's disease, 22,23 and one that also meets the "Lipinski rule of 5" 24 criteria for its representative molecular and crystallographic parameters 25 within the pharmaceutical drug subset. 26 Entacapone has two well-characterized polymorphic forms (A and D), each of which have distinctly different crystal structures, external morphologies and crystallization behavior.…”